Biochemical Markers of Platelet Activation

Szczeklik A, Gryglewski RJ, Musial J, Grodzinska L, Serwonska M, Marcinkiewicz E. Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemost 1978;40:66–74. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981;304:685–691. Levine SP, Lindenfeld J, Ellis JB, Raymond NM, Krentz LS. Increased plasma concentrations of platelet factor 4 in coronary artery disease: A measure of in vivo platelet activation and secretion. Circulation 1981;64:626–632. Rubenstein MD, Wall RT, Baim DS, Harrison DC. Platelet activation in clinical coronary artery disease and spasm. Am Heart J 1981;102:363–367. Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney J, Ploetz J, Kurland G. Circulating platelet products in unstable angina pectoris. Circulation 1981;63:300–306. de Boer AC, Turpie AG, Butt RW, Johnston RV, Genton E. Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation 1982;66:327–333. Hirsh PD, Firth BG, Campbell WB, Dehmer GJ, Willerson JT, Hillis LD. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. Am J Cardiol 1983;Mar 1 51:727–733. Douste-Blazy P, Sie P, Boneu B, Marco J, Eche N, Bernadet P. Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogram. Thromb Haemost 1984;52:297–300. Mehta J, Mehta P, Feldman RL, Horalek C. Thromboxane release in coronary artery disease: Spontaneous versus pacing-induced angina. Am Heart J 1984;107:286–292. Gallino A, Haeberli A, Baur HR, Straub PW. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: Relationship with the degree of myocardial ischemia. Circulation 1985;72:27–30. Mueller HS, Rao PS, Greenberg MA, et al. Systemic and transcardiac platelet activity in acute myocardial infarction in man: Resistance to prostacyclin. Circulation 1985;72:1336–1345. Neri Serneri GG, Gensini GF, Abbate R, et al. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. Am Heart J 1985;109:732–738. Foegh ML, Eliasen K, Johansen S, Helfrich GB, Ramwell PW. Coronary artery thrombosis and elevated urine immunoreactive thromboxane B2. Prostaglandins 1986;32:781–788. Henriksson P, Wennmalm A, Edhag O, Vesterqvist O, Green K. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. Br Heart J 1986;55:543–548. Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986;314:937–942. Prisco D, Rogasi PG, Matucci M, Abbate R, Gensini GF, Serneri GG. Increased thromboxane A2 generation and altered membrane fatty acid composition in platelets from patients with active angina pectoris. Thromb Res 1986;44:101–112. Reilly IA, Doran JB, Smith B, FitzGerald GA. Increased thromboxane biosynthesis in a human preparation of platelet activation: Biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 1986;73: 1300–1309. Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC. Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 1987;10: 998–1006. Neri Serneri GG, Abbate R, Panetta A, Pinto S, Favilla S, Prisco D, Gensini GF. Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina. Thromb Res 1987;46:303–316. Nichols AB, Gold KD, Marcella JJ, Cannon PJ, Owen J. Effect of pacing-induced myocardial ischemia on platelet activation and fibrin formation in the coronary circulation. J Am Coll Cardiol 1987;10:40–45. Swahn E, Wallentin L. Platelet reactivity in unstable coronary artery disease. Thromb Haemost 1987;57:302–305. Theroux P, Latour JG, Leger-Gauthier C, De Lara J. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987;75:156–162. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988;77:142–150. Fitzgerald DJ, Wright F, FitzGerald GA. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Circ Res 1989;65:83–94. Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ. Platelet and vascular function during coronary thrombolysis with tissuetype plasminogen activator. Circulation 1989;80:1718–1725. Nidorf SM, Sturm M, Strophair J, Kendrew PJ, Taylor RR. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. Cardiovasc Res 1989;23:273–278. Dorn GW 2d, Liel N, Trask JL, Mais DE, Assey ME, Halushka PV. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation 1990;81:212–218. Lorenz RL, Hamm CW, Riesner H, Bleifeld W, Weber PC. A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest pain. J Intern Med 1990;227:429–434. Vejar M, Fragasso G, Hackett D, et al. Dissociation of platelet